Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts.

Lang P, Barbin K, Feuchtinger T, Greil J, Peipp M, Zunino SJ, Pfeiffer M, Handgretinger R, Niethammer D, Fey GH.

Blood. 2004 May 15;103(10):3982-5. Epub 2004 Feb 5.

2.

Rituximab mediates in vitro antileukemic activity in pediatric patients after allogeneic transplantation.

Pfeiffer M, Stanojevic S, Feuchtinger T, Greil J, Handgretinger R, Barbin K, Jung G, Martin D, Niethammer D, Lang P.

Bone Marrow Transplant. 2005 Jul;36(2):91-7.

PMID:
15908973
3.

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect.

Cooper LJ, Topp MS, Serrano LM, Gonzalez S, Chang WC, Naranjo A, Wright C, Popplewell L, Raubitschek A, Forman SJ, Jensen MC.

Blood. 2003 Feb 15;101(4):1637-44. Epub 2002 Oct 10.

4.

Effective lysis of lymphoma cells with a stabilised bispecific single-chain Fv antibody against CD19 and FcgammaRIII (CD16).

Bruenke J, Barbin K, Kunert S, Lang P, Pfeiffer M, Stieglmaier K, Niethammer D, Stockmeyer B, Peipp M, Repp R, Valerius T, Fey GH.

Br J Haematol. 2005 Jul;130(2):218-28.

PMID:
16029450
5.

Immunological aspects of haploidentical stem cell transplantation in children.

Handgretinger R, Lang P, Schumm M, Pfeiffer M, Gottschling S, Demirdelen B, Bader P, Kuci S, Klingebiel T, Niethammer D.

Ann N Y Acad Sci. 2001 Jun;938:340-57; discussion 357-8.

PMID:
11458522
6.

Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children.

Koehl U, Esser R, Zimmermann S, Tonn T, Kotchetkov R, Bartling T, Sörensen J, Grüttner HP, Bader P, Seifried E, Martin H, Lang P, Passweg JR, Klingebiel T, Schwabe D.

Klin Padiatr. 2005 Nov-Dec;217(6):345-50.

PMID:
16307421
7.

NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.

Moga E, Alvarez E, Cantó E, Vidal S, Rodríguez-Sánchez JL, Sierra J, Briones J.

Exp Hematol. 2008 Jan;36(1):69-77. Epub 2007 Oct 23.

PMID:
17959301
8.

Targeting of natural killer-like T immunologic effector cells against leukemia and lymphoma cells by reverse antibody-dependent cellular cytotoxicity.

Lefterova P, Märten A, Buttgereit P, Weineck S, Scheffold C, Huhn D, Schmidt-Wolf IG.

J Immunother. 2000 May-Jun;23(3):304-10.

PMID:
10838659
9.

Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors.

Lang P, Griesinger A, Hamprecht K, Feuchtinger T, Schumm M, Neuhäuser F, Greil J, Martin D, Handgretinger R, Niethammer D.

Hum Immunol. 2004 May;65(5):423-31.

PMID:
15172441
10.

Enhancement of the anti-leukemic activity of cytokine induced killer cells with an anti-CD19 chimeric receptor delivering a 4-1BB-zeta activating signal.

Marin V, Kakuda H, Dander E, Imai C, Campana D, Biondi A, D'Amico G.

Exp Hematol. 2007 Sep;35(9):1388-97. Epub 2007 Jul 25.

PMID:
17656004
11.

Influence of variable N-glycosylation on the cytolytic potential of chimeric CD19 antibodies.

Barbin K, Stieglmaier J, Saul D, Stieglmaier K, Stockmeyer B, Pfeiffer M, Lang P, Fey GH.

J Immunother. 2006 Mar-Apr;29(2):122-33.

PMID:
16531813
12.

A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study.

Lang P, Schumm M, Greil J, Bader P, Klingebiel T, Müller I, Feuchtinger T, Pfeiffer M, Schlegel PG, Niethammer D, Handgretinger R.

Klin Padiatr. 2005 Nov-Dec;217(6):334-8.

PMID:
16307419
13.

Adoptive cellular immunotherapy with CD19-specific T cells.

Rössig C, Pscherer S, Landmeier S, Altvater B, Jürgens H, Vormoor J.

Klin Padiatr. 2005 Nov-Dec;217(6):351-6.

PMID:
16307422
14.

Clinical scale isolation of T cell-depleted CD56+ donor lymphocytes in children.

Lang P, Pfeiffer M, Handgretinger R, Schumm M, Demirdelen B, Stanojevic S, Klingebiel T, Köhl U, Kuci S, Niethammer D.

Bone Marrow Transplant. 2002 Mar;29(6):497-502.

15.
16.
17.

Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.

Wang W, Nishioka Y, Ozaki S, Jalili A, Verma VK, Hanibuchi M, Abe S, Minakuchi K, Matsumoto T, Sone S.

Lung Cancer. 2009 Jan;63(1):23-31. doi: 10.1016/j.lungcan.2008.04.009. Epub 2008 Jun 3.

PMID:
18524412
19.

Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells.

Stangl S, Gross C, Pockley AG, Asea AA, Multhoff G.

Cell Stress Chaperones. 2008 Summer;13(2):221-30. doi: 10.1007/s12192-007-0008-y. Epub 2008 Feb 26.

20.

Haploidentical stem cell transplantation in patients with pediatric solid tumors: preliminary results of a pilot study and analysis of graft versus tumor effects.

Lang P, Pfeiffer M, Müller I, Schumm M, Ebinger M, Koscielniak E, Feuchtinger T, Föll J, Martin D, Handgretinger R.

Klin Padiatr. 2006 Nov-Dec;218(6):321-6.

PMID:
17080334
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk